Wearable remote monitoring for clinical trials of NCD interventions (DISEASE-01)

RDS SAS (Strasbourg, France, founded 2020) develops MultiSense®, a wireless multi-parameter patch and remote patient monitoring platform. The patch has been clinically evaluated against ICU gold-standard monitoring (Eurostars project DARE), and we work with 20+ hospital partners in France and Europe.

For HORIZON-HLTH-2027-02-DISEASE-01, MultiSense can serve as:

• the core of a non-pharmacological intervention, such as remote-monitoring-guided management of heart failure, COPD or hypertension; or

• the continuous monitoring layer of a trial, capturing safety, efficacy and long-term outcomes at home.

RDS provides devices, the platform, deployment support, alert and endpoint algorithms, and real-world physiological data for health-economic analysis.

We are looking for a clinical coordinator whose intervention has proof-of-concept for safety and efficacy, as well as partners in health economics and patient organisations.